ECHO EchoStar CORP Insider Trading

CLO Dean Manson sold 10,000 shares at $130.39 via scheduled 10b5-1 plan; retains 5,058 non-derivative shares plus 61,700 options.

Dean Manson, Chief Legal Officer, executed 2 separate sales totaling 10,000 shares for $1,303,900.00 on 2026-06-12, part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-05. The transactions occurred at $130.39 per share, while the current price stands at $120.97, representing a decline of -17.8% from the 52-week high of $147.25. His non-derivative holdings fell from 15,058 to 5,058 shares, but his overall position remains significant at 61,700 shares via employee stock options (28,000 and 33,700 shares across two separate options). EchoStar faces headwinds: the company posted a net loss of $-146,885,000.00 over its most recent full fiscal year, with annual revenue declining -5.2% year-over-year and current quarterly revenue at $3,667,489,000.00. The scheduled nature of this trade removes discretionary timing considerations; investors should focus on the company's operational context—unprofitability and revenue contraction—rather than interpreting the sale as a timed market signal.

Hamid Akhavan (then-CEO, EchoStar Capital) sold 52,586 shares for $6,362,906 under pre-arranged 10b5-1 plan

Hamid Akhavan, who was CEO at the time, executed 2 separate sales totaling 52,586 shares for $6,362,906 at $121.00 on 2026-06-05 as part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-06. The sales reduced his non-derivative holdings from 931,123 shares to 878,537 shares (-5.6%), though he retains 40,834 employee stock options. The sale occurred when the stock was trading at a 20.7% discount to its 52-week high of $147.25 and has declined 8.2% over the prior 30 days. His prior trades at SATS show strong post-sale appreciation, with 30-day returns ranging from +12.4% to +19.7% after sales, but this transaction is scheduled under a pre-arranged plan rather than discretionary. EchoStar remains unprofitable, with $-146.9M net income in its latest full fiscal year and annual revenue declining 5.2% year-over-year, providing context around company fundamentals during the sale window.

CLO Dean Manson sells 10,000 SATS shares at $119.50 under pre-arranged 10b5-1 plan; retains 5,058 shares plus 32,000 options

Dean Manson, Chief Legal Officer, completed a scheduled sale of 10,000 shares of EchoStar (SATS) at $119.50 on 2026-06-04 under a pre-arranged 10b5-1 trading plan adopted 2026-03-05. This is a non-discretionary, scheduled transaction; the stock has declined 8.3% over the prior 30 days and trades -20.8% below its 52-week high of $147.25. The company faces headwinds: it generated -$146.9M net income in the latest quarter, annual revenue contracted 5.2% year-over-year, and the company remains unprofitable on a full-year basis. Manson's prior trades at SATS show mixed near-term outcomes (ranging from -17.9% to +12.4% over 30 days), though his cross-ticker record averaged +36.9% over 90 days post-sale. Because this transaction is scheduled under a 10b5-1 plan rather than discretionary, it does not convey timing judgment. Manson retains 5,058 non-derivative shares and 32,000 employee stock options, preserving material equity exposure.

CEO Akhavan Hamid sells 71,005 shares of SATS at $107.52 for $7.6M; retains 823,293 shares amid unprofitable operations.

Akhavan Hamid, CEO of EchoStar Capital, executed a sale of 71,005 shares at $107.52 on 2026-03-06, reducing his holdings by 7.9% to 823,293 shares. The company is currently unprofitable with net income of $-12.8B against revenue of $3.6B, and annual revenue declined 5.2% year-over-year. This sale occurs with the stock trading -17.2% from its 52-week high of $131.09, following a 30-day decline of -2.8%. His prior five transactions at SATS (all on 2025-12-11) showed positive 30-day returns ranging from 10.2% to 15.3%, though 90-day outcome data is not yet measurable for those trades. This sale represents a partial reduction of an already-substantial executive position in a financially distressed company.

CLO Manson Dean sold 19,031 shares at $114.56 average price, reducing holdings by 79.2%, while company remains unprofitable with -5.2% annual revenue growth.

Manson Dean, Chief Legal Officer, executed 2 separate sales totaling 19,031 shares for $2,180,265.81, reducing his stake from 24,029 shares to 4,998 shares. The magnitude of the reduction (79.2% of prior holdings) is substantial for an executive officer whose residual position is now relatively modest at 5.0K shares. EchoStar operates in fundamentally challenged territory: net income was $-12,781,196,000.00 for the most recent full fiscal year, annual revenue contracted 5.2% year-over-year, and the company trades at a market cap of $5,241,759,326.88. The current price of $109.92 is down 16.2% from the 52-week high, suggesting recent depreciation from the sale prices ($114.51–$114.60). Dean's prior same-ticker history shows 2 prior sells that were not well-timed at the 90-day mark (posting positive subsequent returns of +8.6% and +127.8%), indicating his historical sales have not preceded declines at this ticker.

COO John Swieringa sells 50,088 shares (50.1K) at blended $113.58; stock now -19.0% from 52-week high, EchoStar unprofitable

Swieringa executed two separate sales totaling 50,088 shares for $5,689,228.32 at prices near $113–$114, reducing his stake by 16.5% to 253.5K shares. The timing is noteworthy: the stock has declined -4.0% in 30 days and stands 19.0% below its 52-week peak at the current price of $106.24. At SATS specifically, Swieringa's prior five sales (particularly the November 2025 sale showing 54.3% gain in 30 days) did not exhibit well-timed exit patterns at the 90-day mark—none of those five prior trades achieved negative 90-day returns, meaning the insider has not historically sold before subsequent declines at this ticker. The company backdrop is difficult: revenue declined 5.2% year-over-year, and net income was -$12.8B over the full fiscal year, making EchoStar significantly unprofitable. This combination—a large executive sale during weakness, a history of poorly-timed exits at this ticker, and deteriorating fundamentals—warrants attention to whether this sale reflects operational realities that may pressure the stock further.

Former EchoStar CEO Hamid sells 285,832 shares for $30.1M via pre-arranged 10b5-1 plan on 2025-12-11

Akhavan Hamid, who was CEO of EchoStar Capital, executed 24 separate sales totaling 285,832 shares for $30,106,498.58 at a blended average price of $105.33 on 2025-12-11, reducing his holdings by 43.1% from 662,637 to 376,805 shares. This large-scale divestiture is governed by a 10b5-1 trading plan adopted on 2025-09-12, indicating the sales were scheduled in advance rather than discretionary responses to current market conditions. The multi-tranche nature of the sales—executed across varying price points from $104.09 to $108.92—is consistent with algorithmic execution typical of pre-arranged plans designed to distribute selling pressure. Investors should note the substantial reduction in insider holdings and verify whether Hamid retains material stock ownership or whether this represents near-complete position liquidation.

EchoStar COO Swieringa sells 22,000 shares ($1.5M) at $67.34; stock now down 15.0% from 52-week high amid -$12.8B net loss

Swieringa sold 22,000 shares at $67.34 on 2025-11-21, reducing his position by 7.2% to 283,509 shares. The sale occurred when EchoStar's stock was -15.0% from its 52-week high of $83.57 and the company reported a net loss of -$12.8B against revenue of $3.6B, with annual revenue contracting -7.0% year-over-year. His prior five sales at SATS all posted 30-day returns of -5.8%, and his cross-ticker track record shows an average 30-day return of -5.8% on five prior sells, though measurable timing outcomes at this ticker remain incomplete. The sale occurs in a context of deteriorating fundamentals and sustained stock weakness relative to recent highs.

Director Brokaw bought 1,000 SATS shares at $68.07 on 2025-11-18; stock now $67.23, -19.6% from 52-week high.

Director George R Brokaw purchased 1,000 shares at $68.07, increasing his holdings by 57.0% to 2,754 shares post-transaction. The transaction occurred near the lower end of the 52-week range ($15.99–$83.57) and the stock has since declined to $67.23, -8.9% in the past 30 days. However, EchoStar reported a net loss of $-12.8B in its latest quarter, annual revenue contracted -7.0% year-over-year, and the company was unprofitable over its most recent full fiscal year—fundamentals that provide little support for the purchase decision. Brokaw's cross-ticker track record shows only 1 prior open-market buy with a 0.00% win rate at the 90-day horizon, limiting confidence in the reliability of his prior trades as a positive signal.

CEO Hamid sells 233,918 shares for $17.6M at blended $75.35; retains 376,805 shares post-sale.

Akhavan Hamid, President and CEO, executed 2 separate sales totaling 233,918 shares for $17,626,533.32, reducing his holdings by 38.3% from 610,723 to 376,805 shares. The transactions occurred at prices ($74.93 and $76.50) well above the current market price of $69.80, suggesting execution during a period of relative strength. EchoStar reported negative net income of $-306,844,000.00 in its latest quarter and annual revenue declined 7.0% year-over-year, yet the stock has appreciated 150.5% over the prior 30 days and 180.7% over 90 days, possibly reflecting market recovery or sector rotation. The CEO's substantial reduction in equity stake during strong recent price momentum, coupled with the company's ongoing unprofitability and revenue contraction, merits investor attention to understand the strategic context behind the divestiture.